Awada A - Search Results

1

Phase I and pharmacokinetic studies of topotecan administered as a 72 or 120 h continuous infusion.

Burris HA 3rd, Awada A, Kuhn JG, Eckardt JR, Cobb PW, Rinaldi DA, Fields S, Smith L, Von Hoff DD. Burris HA 3rd, et al. Among authors: awada a. Anticancer Drugs. 1994 Aug;5(4):394-402. doi: 10.1097/00001813-199408000-00002. Anticancer Drugs. 1994. PMID: 7949242 Clinical Trial.

2

Pharmacokinetic and phase I studies of brequinar (DUP 785; NSC 368390) in combination with cisplatin in patients with advanced malignancies.

Burris HA 3rd, Raymond E, Awada A, Kuhn JG, O'Rourke TJ, Brentzel J, Lynch W, King SY, Brown TD, Von Hoff DD. Burris HA 3rd, et al. Among authors: awada a. Invest New Drugs. 1998;16(1):19-27. doi: 10.1023/a:1016066529642. Invest New Drugs. 1998. PMID: 9740540 Clinical Trial.

3

Phase I dose escalation study of weekly ixabepilone, an epothilone analog, in patients with advanced solid tumors who have failed standard therapy.

Awada A, Piccart MJ, Jones SF, Peck RA, Gil T, Lebwohl D, Wu CY, Burris HA 3rd. Awada A, et al. Cancer Chemother Pharmacol. 2009 Feb;63(3):417-25. doi: 10.1007/s00280-008-0751-5. Epub 2008 Apr 29. Cancer Chemother Pharmacol. 2009. PMID: 18446338 Clinical Trial.

4

An open-label, dose-escalation study to evaluate the safety and pharmacokinetics of CEP-9722 (a PARP-1 and PARP-2 inhibitor) in combination with gemcitabine and cisplatin in patients with advanced solid tumors.

Awada A, Campone M, Varga A, Aftimos P, Frenel JS, Bahleda R, Gombos A, Bourbouloux E, Soria JC. Awada A, et al. Anticancer Drugs. 2016 Apr;27(4):342-8. doi: 10.1097/CAD.0000000000000336. Anticancer Drugs. 2016. PMID: 26796987

5

Phase I dose-escalation study of plitidepsin in combination with bevacizumab in patients with refractory solid tumors.

Aspeslagh S, Awada A, S Matos-Pita A, Aftimos P, Bahleda R, Varga A, Soria JC. Aspeslagh S, et al. Among authors: awada a. Anticancer Drugs. 2016 Nov;27(10):1021-7. doi: 10.1097/CAD.0000000000000409. Anticancer Drugs. 2016. PMID: 27610894 Clinical Trial.

6

First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors.

Kim TW, Burris HA, de Miguel Luken MJ, Pishvaian MJ, Bang YJ, Gordon M, Awada A, Camidge DR, Hodi FS, McArthur GA, Miller WH, Cervantes A, Chow LQ, Lesokhin AM, Rutten A, Sznol M, Rishipathak D, Chen SC, Stefanich E, Pourmohamad T, Anderson M, Kim J, Huseni M, Rhee I, Siu LL. Kim TW, et al. Among authors: awada a. Clin Cancer Res. 2022 Aug 15;28(16):3452-3463. doi: 10.1158/1078-0432.CCR-21-4020. Clin Cancer Res. 2022. PMID: 35699599 Free PMC article. Clinical Trial.

7

Prolonged schedule of temozolomide (Temodal) plus liposomal doxorubicin (Caelyx) in advanced solid cancers.

Awada A, Gil T, Sales F, Dubuisson M, Vereecken P, Klastersky J, Moerman C, de Valeriola D, Piccart MJ. Awada A, et al. Anticancer Drugs. 2004 Jun;15(5):499-502. doi: 10.1097/01.cad.0000127331.29310.8a. Anticancer Drugs. 2004. PMID: 15166625 Clinical Trial.

8

A phase I dose-finding clinical pharmacokinetic study of an oral formulation of irinotecan (CPT-11) administered for 5 days every 3 weeks in patients with advanced solid tumours.

Dumez H, Awada A, Piccart M, Assadourian S, Semiond D, Guetens G, de Boeck G, Maes RA, de Bruijn EA, van Oosterom A. Dumez H, et al. Among authors: awada a. Ann Oncol. 2006 Jul;17(7):1158-65. doi: 10.1093/annonc/mdl071. Epub 2006 Apr 6. Ann Oncol. 2006. PMID: 16600980 Free article. Clinical Trial.

9

Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours.

Awada A, Hendlisz A, Gil T, Bartholomeus S, Mano M, de Valeriola D, Strumberg D, Brendel E, Haase CG, Schwartz B, Piccart M. Awada A, et al. Br J Cancer. 2005 May 23;92(10):1855-61. doi: 10.1038/sj.bjc.6602584. Br J Cancer. 2005. PMID: 15870716 Free PMC article. Clinical Trial.

10

Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis.

Tomiak E, Piccart MJ, Kerger J, Lips S, Awada A, de Valeriola D, Ravoet C, Lossignol D, Sculier JP, Auzannet V, et al. Tomiak E, et al. Among authors: awada a. J Clin Oncol. 1994 Jul;12(7):1458-67. doi: 10.1200/JCO.1994.12.7.1458. J Clin Oncol. 1994. PMID: 7912725 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

557 results

Search Page

Filters